1 – 59 of 59
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Acromegaly management in the Nordic countries: A Delphi consensus survey
(
- Contribution to journal › Article
- 2023
-
Mark
Salivary cortisol and cortisone in diagnosis of Cushing's syndrome - A comparison of six different analytical methods
(
- Contribution to journal › Article
-
Mark
Aggressive pituitary tumors and pituitary carcinomas : from pathology to treatment
(
- Contribution to journal › Article
-
Mark
Initial pathology in aggressive pituitary tumours and carcinomas : 2b or not 2b?-that is the question
(
- Contribution to journal › Article
-
Mark
Long-term Follow-up of 84 Patients With Giant Prolactinomas-A Swedish Nationwide Study
(
- Contribution to journal › Article
-
Mark
Establishing a valid cohort of patients with acromegaly by combining the National Patient Register with the Swedish Pituitary Register
2023) In Journal of Endocrinological Investigation(
- Contribution to journal › Article
-
Mark
Prevalence and clinical correlations of SF3B1 variants in lactotroph tumours
(
- Contribution to journal › Article
- 2022
-
Mark
Long-term outcomes of patients with acromegaly : a report from the Swedish Pituitary Register
(
- Contribution to journal › Article
-
Mark
Natural history and surgical outcome of Rathke's cleft cysts—A study from the Swedish Pituitary Registry
(
- Contribution to journal › Article
-
Mark
Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients
(
- Contribution to journal › Article
-
Mark
Pituitary function and the response to GH therapy in patients with Langerhans cell histiocytosis : analysis of the KIMS database
(
- Contribution to journal › Article
-
Mark
Increased Mortality Persists after Treatment of Cushing's Disease : A Matched Nationwide Cohort Study
(
- Contribution to journal › Article
- 2021
-
Mark
Improved Urinary Cortisol Metabolome in Addison Disease : A Prospective Trial of Dual-Release Hydrocortisone
(
- Contribution to journal › Article
-
Mark
Corticotroph Aggressive Pituitary Tumors and Carcinomas Frequently Harbor ATRX Mutations
(
- Contribution to journal › Article
-
Mark
11C-Metomidate PET/CT Detected Multiple Ectopic Adrenal Rest Tumors in a Woman with Congenital Adrenal Hyperplasia
(
- Contribution to journal › Article
-
Mark
Psychotropic Drugs in Patients with Cushing's Disease Before Diagnosis and at Long-Term Follow-Up : A Nationwide Study
(
- Contribution to journal › Article
-
Mark
Prevalence of Nelson’s syndrome after bilateral adrenalectomy in patients with cushing’s disease : a systematic review and meta-analysis
(
- Contribution to journal › Article
- 2020
-
Mark
Are aggressive pituitary tumors and carcinomas two sides of the same coin? Pathologists reply to clinician’s questions
(
- Contribution to journal › Scientific review
-
Mark
Temozolomide therapy for aggressive pituitary tumours – current understanding and future perspectives
(
- Contribution to journal › Scientific review
-
Mark
Excess Morbidity Persists in Patients With Cushing's Disease During Long-term Remission : A Swedish Nationwide Study
(
- Contribution to journal › Article
-
Mark
Reference intervals of salivary cortisol and cortisone and their diagnostic accuracy in Cushing's syndrome
(
- Contribution to journal › Article
-
Mark
Early versus late initiation of GH replacement in adult-onset hypopituitarism
(
- Contribution to journal › Article
- 2019
-
Mark
The incidence of Cushing’s disease : a nationwide Swedish study
(
- Contribution to journal › Article
-
Mark
Pituitary Metastases : A Nationwide Study on Current Characteristics with Special Reference to Breast Cancer
(
- Contribution to journal › Article
-
Mark
Change in baseline characteristics over 20 years of adults with growth hormone (GH) deficiency on GH replacement therapy
(
- Contribution to journal › Article
-
Mark
Overall and Disease-Specific Mortality in Patients With Cushing Disease: A Swedish Nationwide Study
(
- Contribution to journal › Article
- 2018
-
Mark
Relative risks of contributing factors to morbidity and mortality in adults with craniopharyngioma on growth hormone replacement
(
- Contribution to journal › Article
-
Mark
European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas
(
- Contribution to journal › Article
-
Mark
Temporal relationship of sleep apnea and acromegaly : a nationwide study
(
- Contribution to journal › Article
-
Mark
Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide
(
- Contribution to journal › Letter
-
Mark
Aggressive pituitary tumours and carcinomas : two sides of the same coin?
(
- Contribution to journal › Scientific review
-
Mark
Treatment of aggressive pituitary tumours and carcinomas : results of a European Society of Endocrinology (ESE) survey 2016
(
- Contribution to journal › Article
- 2017
-
Mark
Radiotherapy, especially at young age, increases the risk for de novo brain tumors in patients treated for pituitary/sellar lesions
(
- Contribution to journal › Article
-
Mark
Development of ACRODAT®, a new software medical device to assess disease activity in patients with acromegaly
(
- Contribution to journal › Article
-
Mark
Corticotroph Pituitary Carcinoma in a Patient With Lynch Syndrome (LS) and Pituitary Tumors in a Nationwide LS Cohort
(
- Contribution to journal › Article
-
Mark
Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency : a phase 3b, open-label, extension study
(
- Contribution to journal › Article
-
Mark
A permissive role of growth hormone (GH) in the development of second brain tumors after radiotherapy?
(
- Contribution to journal › Letter
- 2016
-
Mark
Limited value of cabergoline in Cushing's disease: a prospective study of a 6-week treatment in 20 patients.
(
- Contribution to journal › Article
-
Mark
GH Safety Workshop Position Paper: a critical appraisal of recombinant human growth hormone therapy in children and adults.
(
- Contribution to journal › Article
- 2015
-
Mark
Truncated somatostatin receptor 5 may modulate therapy response to somatostatin analogues - Observations in two patients with acromegaly and severe headache.
(
- Contribution to journal › Article
-
Mark
ESE guidelines, why and how.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Long-term outcome and MGMT as a predictive marker in 24 patients with atypical pituitary adenomas and pituitary carcinomas given treatment with temozolomide.
(
- Contribution to journal › Article
- 2014
-
Mark
Prospective evaluation of long-term safety of dual-release hydrocortisone replacement administered once daily in patients with adrenal insufficiency.
(
- Contribution to journal › Article
-
Mark
Giant prolactinomas in women
(
- Contribution to journal › Article
- 2013
-
Mark
Deaths Among Adult Patients with Hypopituitarism: Hypocortisolism During Acute Stress, and De Novo Malignant Brain Tumors Contribute to an Increased Mortality.
(
- Contribution to journal › Article
-
Mark
National Incidence and Prevalence of TSH-Secreting Pituitary Adenomas in Sweden.
(
- Contribution to journal › Article
- 2011
-
Mark
Improved Cortisol Exposure-Time Profile and Outcome in Patients with Adrenal Insufficiency: A Prospective Randomized Trial of a Novel Hydrocortisone Dual-Release Formulation.
(
- Contribution to journal › Article
-
Mark
Favorable long-term effects of growth hormone replacement therapy on quality of life, bone metabolism, body composition and lipid levels in patients with adult-onset growth hormone deficiency
(
- Contribution to journal › Article
-
Mark
Interleukin 1 receptor antagonist is associated with changes in body composition during physiological GH substitution in patients with adult-onset growth hormone deficiency.
(
- Contribution to journal › Article
- 2010
-
Mark
Improved Quality of Life in Patients with Primary Adrenal Insufficiency by Using a Novel Once-Daily Dual Release Hydrocortisone Tablet: A Randomised Controlled, Cross-Over Trial.
(
- Contribution to journal › Published meeting abstract
-
Mark
Large fat and skin necroses after deep subcutaneous injections of a slow-release somatostatin analogue in a woman with acromegaly.
(
- Contribution to journal › Article
-
Mark
Recurrence of Hyperprolactinemia after Withdrawal of Dopamine Agonists: Systematic Review and Meta-Analysis.
(
- Contribution to journal › Article
- 2009
-
Mark
Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations
(
- Contribution to journal › Article
- 2008
-
Mark
Follow-up of pituitary tumor volume in patients with acromegaly treated with pegvisomant in clinical trials
(
- Contribution to journal › Article
- 2007
-
Mark
Effects of GH on cognitive function in elderly patients with adult-onset GH deficiency: a placebo-controlled 12-month study
(
- Contribution to journal › Article
-
Mark
Gender, body weight, disease activity, and previous radiotherapy influence the response to pegvisomant
(
- Contribution to journal › Article
- 2006
-
Mark
The effects of growth hormone (GH) deficiency and GH replacement on cognitive performance in adults: A meta-analysis of the current literature
(
- Contribution to journal › Article
- 2005
-
Mark
Low-dose GH improves exercise capacity in adults with GH deficiency: effects of a 22-month placebo-controlled, crossover trial
(
- Contribution to journal › Article
- 1995
-
Mark
Quality of life in adults with growth hormone (GH) deficiency : response to treatment with recombinant human GH in a placebo-controlled 21-month trial
(
- Contribution to journal › Article